Dentzer James E

Dentzer James E is listed in filings as Director at Imunon, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including 13 public disclosures. Recent filings connect the profile to Imunon, Inc. (IMNN) and Curis, Inc. (CRIS). The current snapshot covers public activity from Jun 14, 2024 to May 27, 2026. Reported amounts are shown as $24.5K to $17.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.